DJ, M., SJ, Y., PM, D., HC, H., GW, S., C, M., . . . Stone, G. W. (2002). Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: The TARGET follow-up study. Lancet, 360(9330), 355. https://doi.org/10.1016/s0140-6736(02)09605-8
Chicago Style (17th ed.) CitationDJ, Moliterno, et al. "Outcomes at 6 Months for the Direct Comparison of Tirofiban and Abciximab During Percutaneous Coronary Revascularisation with Stent Placement: The TARGET Follow-up Study." Lancet 360, no. 9330 (2002): 355. https://doi.org/10.1016/s0140-6736(02)09605-8.
MLA (9th ed.) CitationDJ, Moliterno, et al. "Outcomes at 6 Months for the Direct Comparison of Tirofiban and Abciximab During Percutaneous Coronary Revascularisation with Stent Placement: The TARGET Follow-up Study." Lancet, vol. 360, no. 9330, 2002, p. 355, https://doi.org/10.1016/s0140-6736(02)09605-8.